MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/11206721211003492

Медицинская библиотека · European journal of ophthalmology · 2021

A case of malignant glaucoma following insertion of Preserflo™ MicroShunt.

Gizzi Corrado, Costa Giacomo, Servadei Roberto, Abed Edoardo, Ning Brigid, Sharma Anant, Barton Keith

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: To describe a case of malignant glaucoma following insertion of a Preserflo™ MicroShunt in a patient with primary open angle glaucoma (POAG).

DESIGN

Case report.

CASE: A 46-year-old Caucasian man with medically uncontrolled POAG developed malignant glaucoma 1 day after an uncomplicated insertion of a mitomycin C (MMC) augmented Preserflo MicroShunt (PMS).

RESULTS

Initial medical treatment with aqueous suppressants and atropine 1% resulted in temporary resolution of the episode, although partial occlusion of the PMS with iris required a Nd:YAG laser iridotomy to open the inlet of the device. However, the malignant glaucoma recurred 6 days later. Temporary resolution was subsequently achieved with an Nd:YAG laser peripheral irido-zonulo-hyaloidotomy in combination with topical atropine, though a subsequent PMS revision was required due to bleb encapsulation. Unfortunately, the revision procedure was followed 2 days later, by a further recurrence of malignant glaucoma which was eventually resolved by left pars plana vitrectomy (PPV) in combination with clear lens extraction (CLE) and surgical irido-zonulo-hyaloidectomy. Subsequently, the eye remained stable, with a deep anterior chamber (AC), a partially functioning bleb, and an intraocular pressure (IOP) of 14 mmHg on one topical IOP-lowering agent, 8 months after the last procedure.

CONCLUSIONS

The management of malignant glaucoma after PMS insertion and its subsequent clinical course is described. Apart from the propensity for a small tube such as the PMS to obstruct with iris when the AC is shallow, management is similar to other scenarios in which malignant glaucoma may develop.

Для цитирования: Gizzi Corrado, Costa Giacomo, Servadei Roberto, Abed Edoardo, Ning Brigid, Sharma Anant, Barton Keith. A case of malignant glaucoma following insertion of Preserflo™ MicroShunt.. European journal of ophthalmology. 2021. DOI: 10.1177/11206721211003492.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.